Brooklyn ImmunoTherapeutics Inc. (BTX): Price and Financial Metrics

Brooklyn ImmunoTherapeutics Inc. (BTX): $4.10

0.00 (0.05%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

C

Add BTX to Watchlist
Sign Up

Industry: Biotech

Industry

NR

Ranked

#167 of 397

in industry

BTX Price/Volume Stats

Current price $4.10 52-week high $10.10
Prev. close $0.21 52-week low $0.17
Day low $3.62 Volume 127,880
Day high $4.20 Avg. volume 515,543
50-day MA $0.36 Dividend yield N/A
200-day MA $1.28 Market Cap 241.30M

BTX Stock Price Chart Interactive Chart >


Brooklyn ImmunoTherapeutics Inc. (BTX) Company Bio


Brooklyn ImmunoTherapeutics, Inc. is a clinical stage biopharmaceutical company that develops IRX-2, a novel hd-IL-2 based therapy, to treat patients with cancer. IRX-2 delivers hd-IL-2 and other key cytokines to restore immune function in the tumor microenvironment, enabling the immune system to attack cancer cells. In a Phase 2a clinical trial, IRX-2 demonstrated an increase in tumor infiltrating lymphocytes, which was associated with a survival benefit in patients with head and neck cancer. The company is headquartered in New York, NY.


BTX Latest News Stream


Event/Time News Detail
Loading, please wait...

BTX Latest Social Stream


Loading social stream, please wait...

View Full BTX Social Stream

BTX Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year -96.88%
5-year -96.06%
YTD N/A
2023 N/A
2022 0.00%
2021 -6.92%
2020 1.82%
2019 12.82%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!